Pancreatic Cancer Clinical Trials

Showing 801-820 of 1,185 trials

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

NCT01806675

The purpose of the study is to conduct research of a new PET radiopharmaceutical in cancer patients. The uptake of the novel radiopharmaceutical 18F-FPPRGD2 will be assessed in study participants with glioblastoma multiforme (GBM), gynecological cancers, and renal cell carcinoma (RCC) who are receiving antiangiogenesis treatment.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more

Sanjiv Sam Gambhir25 participantsStarted Mar 2013

Stanford, California, United States

COMPLETEDPhase 1

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

NCT02574663

This is a Phase 1 multi-center study to assess the safety and efficacy of TGR-1202 as a single agent or in combination with nab-paclitaxel + gemcitabine or with FOLFOX in patients with select relapsed or refractory solid tumors.

Pancreatic CancerColorectal CancerRectal Cancer+3 more

TG Therapeutics, Inc.66 participantsStarted Sep 2015

Nashville, Tennessee, United States

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Related Searches

Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer Patients

RFA RCT for Pancreatic or Bile Duct Cancer

Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors

Effect of Preoperative Immunonutrition in Upper Digestive Tract

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control

Prospective Analysis of Robot-Assisted Surgery

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer

Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection